AAAAAA

   
Results: 1-12 |
Results: 12
TAMOXIFEN OCULAR TOXICITY - PRELIMINARY-RESULTS OF A PROSPECTIVE OBSERVATION TRIAL
Authors: DEUTSCH TA COBLEIGH MA
Citation: Ta. Deutsch et Ma. Cobleigh, TAMOXIFEN OCULAR TOXICITY - PRELIMINARY-RESULTS OF A PROSPECTIVE OBSERVATION TRIAL, Investigative ophthalmology & visual science, 38(4), 1997, pp. 2018-2018
A PHASE-II TRIAL OF COMBINED-MODALITY THERAPY IN STAGE IIIB BREAST-CANCER - IS BREAST-CONSERVING THERAPY (BCT) AN OPTION
Authors: BAKER KF COBLEIGH MA WITT TR GRIEM KL
Citation: Kf. Baker et al., A PHASE-II TRIAL OF COMBINED-MODALITY THERAPY IN STAGE IIIB BREAST-CANCER - IS BREAST-CONSERVING THERAPY (BCT) AN OPTION, Radiology, 205, 1997, pp. 335-335
BRCA1 MUTATIONS IN WOMEN ATTENDING CLINICS THAT EVALUATE THE RISK OF BREAST-CANCER
Authors: COUCH FJ DESHANO ML BLACKWOOD MA CALZONE K STOPFER J CAMPEAU L GANGULY A REBBECK T WEBER BL JABLON L COBLEIGH MA HOSKINS K GARBER JE
Citation: Fj. Couch et al., BRCA1 MUTATIONS IN WOMEN ATTENDING CLINICS THAT EVALUATE THE RISK OF BREAST-CANCER, The New England journal of medicine, 336(20), 1997, pp. 1409-1415
OVARIAN-FUNCTION IN PREMENOPAUSAL WOMEN TREATED WITH ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
Authors: BINES J OLESKE DM COBLEIGH MA
Citation: J. Bines et al., OVARIAN-FUNCTION IN PREMENOPAUSAL WOMEN TREATED WITH ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER, Journal of clinical oncology, 14(5), 1996, pp. 1718-1729
ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - REPLY
Authors: COBLEIGH MA BERRIS RF BUSH T DAVIDSON NE ROBERT NJ SPARANO JA TORMEY DC WOOD WC
Citation: Ma. Cobleigh et al., ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - REPLY, JAMA, the journal of the American Medical Association, 273(8), 1995, pp. 621-621
ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE (VOL 272, PG 540, 1994)
Authors: COBLEIGH MA BERRIS RF BUSH T DAVIDSON NE ROBERT NJ SPARANO JA TORMEY DC WOOD WC
Citation: Ma. Cobleigh et al., ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE (VOL 272, PG 540, 1994), JAMA, the journal of the American Medical Association, 273(5), 1995, pp. 378-378
BREAST-CANCER AND FENRETINIDE, AN ANALOG OF VITAMIN-A
Authors: COBLEIGH MA
Citation: Ma. Cobleigh, BREAST-CANCER AND FENRETINIDE, AN ANALOG OF VITAMIN-A, Leukemia, 8, 1994, pp. 59-63
SEQUENTIAL TRANSPLANTS USING MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS
Authors: GHALIE R RICHMAN CM BENDER JG MCLEOD BC LEE W CZYZEWSKI A MANSON S COBLEIGH MA REED S PIERRE R GEORGE S KAIZER H
Citation: R. Ghalie et al., SEQUENTIAL TRANSPLANTS USING MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS, Journal of clinical apheresis, 9(3), 1994, pp. 176-182
TREATMENT OF METASTATIC BREAST-CANCER WITH A SPLIT-COURSE HIGH-DOSE CHEMOTHERAPY REGIMEN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: GHALIE R RICHMAN CM ADLER SS COBLEIGH MA KORENBLIT AD MANSON SD MCLEOD BC TAYLOR SG VALENTINO LA WOLTER J KAIZER H
Citation: R. Ghalie et al., TREATMENT OF METASTATIC BREAST-CANCER WITH A SPLIT-COURSE HIGH-DOSE CHEMOTHERAPY REGIMEN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 12(2), 1994, pp. 342-346
SHOULD MULTICENTRIC DISEASE BE AN ABSOLUTE CONTRAINDICATION TO THE USE OF BREAST-CONSERVING THERAPY
Authors: HARTSELL WF RECINE DC GREIM KL COBLEIGH MA WITT TR MURTHY AK
Citation: Wf. Hartsell et al., SHOULD MULTICENTRIC DISEASE BE AN ABSOLUTE CONTRAINDICATION TO THE USE OF BREAST-CONSERVING THERAPY, International journal of radiation oncology, biology, physics, 30(1), 1994, pp. 49-53
ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE
Authors: COBLEIGH MA BERRIS RF BUSH T DAVIDSON NE ROBERT NJ SPARANO JA TORMEY DC WOOD WC
Citation: Ma. Cobleigh et al., ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE, JAMA, the journal of the American Medical Association, 272(7), 1994, pp. 540-545
THE PHYSICIAN AS THE PATIENTS ADVOCATE
Authors: GANZ PA BENNETT CL BEREK J COBLEIGH MA COHEN RJ FABIAN C HOLLAND J HUBBARD SM LEVINE MN LOVE RR MORROW M PETERS W SKEEL R
Citation: Pa. Ganz et al., THE PHYSICIAN AS THE PATIENTS ADVOCATE, Journal of clinical oncology, 11(6), 1993, pp. 1011-1013
Risultati: 1-12 |